Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kasperkiewicz

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|December 7, 2018
[Immunoadsorption in dermatology]Franziska Hübner, Michael Kasperkiewicz, Detlef Zillikens, et al.
Cell Stress & Chaperones|May 7, 2014
Hsp90 blockade modulates bullous pemphigoid IgG-induced IL-8 production by keratinocytesStefan Tukaj, Denise Grüner, Detlef Zillikens, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 24, 2012
Immunoadsorption in dermatologyDamian Meyersburg, Enno Schmidt, Michael Kasperkiewicz, et al.
Frontiers in Immunology|March 10, 2018
Targeting IgE Antibodies by Immunoadsorption in Atopic DermatitisMichael Kasperkiewicz, Enno Schmidt, Ralf J Ludwig, et al.
JAAD International|November 11, 2024
Pseudopemphigoid: A systematic reviewBrandon Levian, Syedah S Hussaini, David T Woodley, et al.
JAAD International|July 29, 2025
Bidirectional risk relationship between autoimmune blistering diseases and monoclonal gammopathies: A large-scale matched cohort studyPhilip Curman, Binh T Ngo, Ralf J Ludwig, et al.
Journal of the American Academy of Dermatology|May 28, 2026
Response to Barnawi et al., "Bullous pemphigoid in the era of immunotherapy: Implications for treatment algorithms"Michael Kasperkiewicz, Prince Adotama, Mary M Tomayko, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 21, 2022
A cross-sectional study of dermatologists' attitudes towards COVID-19 vaccination in patients with immunobullous diseasesMichael Kasperkiewicz, Rebecca Strong, Marc Yale, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 14, 2022
Safety of the COVID-19 vaccine booster in patients with immunobullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid FoundationMichael Kasperkiewicz, Rebecca Strong, Marc Yale, et al.
Journal of the American Academy of Dermatology|August 10, 2023
Risk of comorbid autoimmune diseases in patients with immunobullous disorders: A global large-scale cohort studyMichael Kasperkiewicz, Artem Vorobyev, Katja Bieber, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|December 7, 2018
[Immunoadsorption in dermatology]Franziska Hübner, Michael Kasperkiewicz, Detlef Zillikens, et al.
Cell Stress & Chaperones|May 7, 2014
Hsp90 blockade modulates bullous pemphigoid IgG-induced IL-8 production by keratinocytesStefan Tukaj, Denise Grüner, Detlef Zillikens, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 24, 2012
Immunoadsorption in dermatologyDamian Meyersburg, Enno Schmidt, Michael Kasperkiewicz, et al.
Frontiers in Immunology|March 10, 2018
Targeting IgE Antibodies by Immunoadsorption in Atopic DermatitisMichael Kasperkiewicz, Enno Schmidt, Ralf J Ludwig, et al.
JAAD International|November 11, 2024
Pseudopemphigoid: A systematic reviewBrandon Levian, Syedah S Hussaini, David T Woodley, et al.
JAAD International|July 29, 2025
Bidirectional risk relationship between autoimmune blistering diseases and monoclonal gammopathies: A large-scale matched cohort studyPhilip Curman, Binh T Ngo, Ralf J Ludwig, et al.
Journal of the American Academy of Dermatology|May 28, 2026
Response to Barnawi et al., "Bullous pemphigoid in the era of immunotherapy: Implications for treatment algorithms"Michael Kasperkiewicz, Prince Adotama, Mary M Tomayko, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 21, 2022
A cross-sectional study of dermatologists' attitudes towards COVID-19 vaccination in patients with immunobullous diseasesMichael Kasperkiewicz, Rebecca Strong, Marc Yale, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 14, 2022
Safety of the COVID-19 vaccine booster in patients with immunobullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid FoundationMichael Kasperkiewicz, Rebecca Strong, Marc Yale, et al.
Journal of the American Academy of Dermatology|August 10, 2023
Risk of comorbid autoimmune diseases in patients with immunobullous disorders: A global large-scale cohort studyMichael Kasperkiewicz, Artem Vorobyev, Katja Bieber, et al.
Pageof 9